4,995
edits
Metabolic syndrome: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
|||
| Line 37: | Line 37: | ||
==Apple versus the pear shaped body!== | ==Apple versus the pear shaped body!== | ||
Losing a little weight can be especially beneficial for people who store their excess weight in their abdomens, rather than in their hips. This 'apple' pattern of weight distribution means you're at greater risk for heart disease - but it also means you should have an easier time losing the weight, and thus reversing the risk, experts say. | Losing a little weight can be especially beneficial for people who store their excess weight in their abdomens, rather than in their hips. This 'apple' pattern of weight distribution means you're at greater risk for heart disease - but it also means you should have an easier time losing the weight, and thus reversing the risk, experts say. | ||
==Metabolic starvation== | |||
[[Metabolic starvation]] in obese individuals with insulin resistance refers to a situation where the body's cells are not able to efficiently use glucose as a source of energy due to insulin resistance. Despite having high levels of glucose in the bloodstream, the cells are unable to take up and utilize the glucose for energy production. As a result, the cells become "starved" of energy, even though the body has abundant glucose and fat stores. | |||
==Obese and starving== | |||
This phenomenon of starvation while having excess fat stores is commonly seen in obese individuals with insulin resistance, where their bodies become resistant to the effects of insulin. Insulin is a hormone that regulates glucose levels in the bloodstream and helps cells take up glucose and use it for energy. In individuals with insulin resistance, the cells become less sensitive to insulin, leading to an increase in blood glucose levels. This results in an energy crisis in the cells, leading to metabolic starvation. | |||
The metabolic starvation in obese individuals with [[insulin resistance]] can lead to a range of health problems, including type 2 diabetes, cardiovascular disease, and other metabolic disorders. The best way to prevent metabolic starvation in these individuals is to maintain a healthy body weight, eat a balanced diet, and engage in regular physical activity. | |||
==How Can W8MD Weight Loss Centers Help?== | ==How Can W8MD Weight Loss Centers Help?== | ||
| Line 44: | Line 52: | ||
W8MD's program is unique in its approach, combining medical and lifestyle interventions to provide a comprehensive solution to weight loss. Patients are assessed, diagnosed, and treated by licensed physicians and healthcare professionals to ensure the safest and most effective outcomes. The program is designed to help patients lose weight and improve their overall health, reducing the risk of chronic diseases and enhancing quality of life. | W8MD's program is unique in its approach, combining medical and lifestyle interventions to provide a comprehensive solution to weight loss. Patients are assessed, diagnosed, and treated by licensed physicians and healthcare professionals to ensure the safest and most effective outcomes. The program is designed to help patients lose weight and improve their overall health, reducing the risk of chronic diseases and enhancing quality of life. | ||
The best part of W8MD s that we accept health insurance for the visits so you do not have to pay out of pocket for these services. Thanks to the Affordable Care Act, insurances are now mandated to provide coverage for weight loss. | The best part of W8MD s that we accept health insurance for the visits so you do not have to pay out of pocket for these services. Thanks to the Affordable Care Act, [[Insurance coverage for weight loss|insurances]] are now mandated to provide coverage for weight loss. | ||
==References== | |||
* There is a growing body of research that supports the concept of metabolic starvation in obese individuals with insulin resistance. Some relevant references include: | |||
* Cusi K, DeFronzo RA. "Inflammation, insulin resistance, and type 2 diabetes". Endocr Rev. 2005 Dec;26(6):829-41. | |||
* Hotamisligil GS. "Inflammation and metabolic disorders". Nature. 2006 Jun 15;444(7121):860-7. | |||
* Saltiel AR, Kahn CR. "Insulin signalling and the regulation of glucose and lipid metabolism". Nature. 2001 Jan 18;409(6822):972-82. | |||
* Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia". J Clin Endocrinol Metab. 2001 Jan;86(1):1930-5. | |||
==Also see== | ==Also see== | ||